Adiposogenital dystrophy secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}} [[Ogechukwu Hannah Nnabude, MD]] | {{CMG}} [[Ogechukwu Hannah Nnabude, MD]] | ||
==Overview== | |||
There is no secondary prevention available for [[adiposogential dystrophy]]. | |||
==Primary Prevention== | |||
There is no secondary prevention available for [[adiposogential dystrophy]]. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
Latest revision as of 06:30, 29 December 2021
|
Adiposogenital dystrophy Microchapters |
|
Differentiating Adiposogenital dystrophy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Adiposogenital dystrophy secondary prevention On the Web |
|
American Roentgen Ray Society Images of Adiposogenital dystrophy secondary prevention |
|
Risk calculators and risk factors for Adiposogenital dystrophy secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD
Overview
There is no secondary prevention available for adiposogential dystrophy.
Primary Prevention
There is no secondary prevention available for adiposogential dystrophy.